Regencell Bioscience News

Regencell Bioscience | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 2 00:00 ET

Regencell Bioscience | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 15, 2023 06:09 ET

Regencell Bioscience | 20-F: FY2023 Annual Report

Oct 27, 2023 16:15 ET

Regencell Bioscience | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 15, 2023 16:01 ET

Regencell Bioscience | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 5, 2023 06:04 ET

Regencell Bioscience | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 17, 2023 06:03 ET

Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Feb 28, 2023 09:15 ET

Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Jan 4, 2023 08:00 ET

Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Dec 22, 2022 07:00 ET

Regencell Bioscience | 20-F: FY2022 Annual Report

Oct 31, 2022 16:17 ET

Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Sep 12, 2022 09:17 ET

Regencell Bioscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Regencell (BVI) Limited(81.2%),Yat-Gai Au(81.2%)

Jul 26, 2022 08:34 ET

Regencell Bioscience | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 2, 2022 16:16 ET

Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

May 18, 2022 07:57 ET

Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

May 16, 2022 06:23 ET

Regencell Bioscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Regencell (BVI) Limited(81.0%),Yat-Gai Au(81.0%)

May 16, 2022 06:15 ET

Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Apr 26, 2022 08:07 ET

Regencell Bioscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Regencell (BVI) Limited(80.6%),Yat-Gai Au(80.6%)

Apr 4, 2022 07:30 ET

Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Feb 16, 2022 16:30 ET

Regencell Bioscience | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)

Dec 30, 2021 16:05 ET